Home
KSQ Therapeutics

KSQ Therapeutics Market Share Analysis for August 2026

Lexington, Mass., October 8, 2024 — KSQ Therapeutics, Inc. (KSQ), a clinical-stage biotechnology company developing novel treatments for solid tumors, today announced the appointment of Anna Truppel-Hartmann, M.D., as Chief Medical Officer. Dr. Truppel-Hartmann brings an accomplished track record in clinical development, medical affairs, patient engagement, and talent development. She will play a crucial role

Health > Biotechnology and Pharmaceuticals

Domainksqtx.com

Year Founded2015

Employees51 - 200

Annual Revenue$5M - $10M

KSQ Therapeutics

KSQ Therapeutics (including company regionals)

ksqtx.com

See more website traffic and engagement information

KSQ Therapeutics Revenue up to August 2026 is 5M - 10M

revenue generated by KSQ Therapeutics top domains

KSQ Therapeutics top domains revenue over 3 years

Revenue for KSQ Therapeutics top domains

ksqtx.com5M - 10M

See more with Sales Intelligence

Total visits to KSQ Therapeutics's top domains

Understand KSQ Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ksqtx.com4.8K

See more with Sales Intelligence

Avg. visit duration in KSQ Therapeutics's top domains

Analyze KSQ Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ksqtx.com00:00:41

See more with Sales Intelligence

Avg. pageviews on KSQ Therapeutics's top domains

See how KSQ Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ksqtx.com2.54

See more with Sales Intelligence

KSQ Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by KSQ Therapeutics

These are the website technologies, by industry, used by KSQ Therapeutics top domains

Content Management System (3)

WordPress

Widget (3)

Twemoji

Email Services (2)

Microsoft Exchange Online

Mobile (2)

Meta Viewport

More Technologies

6

See all

News & Signals from KSQ Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsKSQ Therapeutics, Inc. hired Kristen Hege as Board of Directors on Mar 5th '25.LEXINGTON, Mass., March 05, 2025 (GLOBE NEWSWIRE) - KSQ Therapeutics, Inc. (KSQ), a clinical-stage biotechnology company developing novel treatments for solid tumors, including engineered tumor-infiltrating lymphocyte (eTIL(R)) programs, today announced the appointment of Kristen Hege, M.D., to the company's Board of Directors.

NewsKSQ Therapeutics, Inc. hired John Lepore as board of directors on Oct 22nd '24.KSQ Therapeutics appoints John Lepore, M.D., to its board of directors.

NewsKSQ Therapeutics, Inc. hired Anna Truppel-Hartmann as Chief Medical Officer on Oct 8th '24.LEXINGTON, Mass., Oct. 08, 2024 (GLOBE NEWSWIRE) - KSQ Therapeutics, Inc. (KSQ), a clinical-stage biotechnology company developing novel treatments for solid tumors, today announced the appointment of Anna Truppel-Hartmann, M.D., as Chief Medical Officer.